The Critical Challenge of Fetal Growth Issues
Fetal growth restriction (FGR) poses serious risks including stillbirth, neonatal mortality, and long-term health complications. Currently, healthcare providers struggle to predict which pregnancies will develop FGR due to limited early detection tools. This groundbreaking study identifies specific biological markers – oxylipins – measurable in early pregnancy that correlate with distinct growth restriction patterns.
